Mucositis in head and neck cancer patients undergoing radiochemotherapy

Revista da Escola de Enfermagem

Volumn 45, Issue 6, 2011, Pages 1338-1344

  Santos, Renata Cristina Schmidt ^a   Dias, Rodrigo Souza ^a   Giordani, Adelmo José ^b   Segreto, Roberto Araújo ^a   Segreto, Helena Regina Comodo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Radiotherapy Sector   (Brazil)

Author keywords

Drug therapy; Head and neck neoplasms; Mucositis; Oncologic nursing; Radiotherapy

Indexed keywords

ARTICLE; CHEMORADIOTHERAPY; COHORT ANALYSIS; FEMALE; HEAD AND NECK TUMOR; HUMAN; MALE; MIDDLE AGED; MOUTH MUCOSA; MUCOSA INFLAMMATION;

CHEMORADIOTHERAPY; COHORT STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MUCOSITIS;

EID: 84857675265     PISSN: 00806234     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0080-62342011000600009     Document Type: Article

References (22)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94(2):153-6.
2. Brasil. Ministério da Saúde; Instituto Nacional do Câncer (INCA). Incidência de câncer no Brasil: estimativa 2010 [Internet]. Rio de Janeiro: INCA; 2009. [citado 2009 set. 15]. Disponível em: http://www.inca.gov.br/estimativa/2010/estimativa20091201.pdf
3. Rose-Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ. Complications of radiation therapy for head and neck cancers: the patient's perspective. Cancer Nurs. 2002;25(6):461-7; quiz 468-9.
4. Denham JW, Peters LJ, Johansen J, Poulsen M, Lamb DS, Hindley A, et al. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck câncer? Radiother Oncol. 1999;52(2):157-64.
5. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100(9 Suppl): 1995-2025.
6. Sawada NO, Nicolussi AC, Okino L, Cardozo FMC, Zago MMF. Quality of life evaluation in cancer patients to submitt ed to chemotherapy. Rev Esc Enferm USP [Internet]. 2009 [cited 2009 Sept 15];43(3):581-7. Available from: http://www.scielo.br/pdf/reeusp/v43n3/en_a12v43n3.pdf
7. Naidu MUR, Ramana GV, Rani PU, Mohan IK, Suman A, Roy P. Chemotherapy-induced and/or therapy-induced oral mucositis-complicating the treatment of cancer. Neoplasia. 2004;6(5):423-31.
8. Saad ED, Hoff PM, Carnelós RP, Katz A, Novis YAS, Pietrocola M, et al. Critérios comuns de toxicidade do Instituto Nacional de Câncer dos Estados Unidos. Rev Bras Cancerol. 2002;48(10):63-96.
9. Porock D. Factors influencing the severity of radiation skin and oral mucosal reactions: development of a conceptual framework. Eur J Cancer Care. 2002;11(1):33-43.
10. Rugg T, Saunders MI, Dische S. Smoking and mucosal reactions to radiotherapy. Br J Radiol. 1990;63(751):554-6.
11. Browman GP, Wong G, Hodson I, Sathya J, Russeli R, Mcalpine L, et al., Influence of cigarett e smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993;328(3):159-63.
12. Mantini G, Manfrida S, Francesco C, Giammarino D, Petrone A, Vitucci P, et al. Impacto of dose and volume on radiationinduced mucositis. Rays. 2005;30(2):137-44.
13. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CG, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003;66(3):253-62.
14. Porock D, Nikoletti S, Cameron F. The relationship between factors that impair wound healing and the severity of acute radiation skin and mucosal toxicities in head and neck cancer. Cancer Nurs. 2004;27(1):71-8.
15. Gelman RS, Taylor SG. Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance. J Clin Oncol. 1984;2(12):1404-13.
16. Ryan ME, Carnu O, Kamer A. The influence of diabetes on the periodontal tissues. J Am Dent Assoc. 2003;134(Spec No):30S-40S.
17. Vera-Lionch M, Oster G, Hagiwara M, Sonis S. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer. 2006;106(2):329-36.
18. Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiationinduced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007;68(4):1110-20.
19. Aziz L, Ebenfelt A. Mucosal secretion changes during radiotherapy in the oral cavity. Clin Oral Investig. 2007;11(3):293-6.
20. Baker DG. The radiobiological basis for tissue reactions in the oral cavity following therapeutic x-irradiation: a review. Arch Otolaryngol. 1982;108(1):21-4.
21. Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol. 2003;39(2):91-100.
22. Soell M, Hassan M, Miliauskaite A, Haikel Y, Selimovic D. The oral cavity of elderly patients in diabetes. Diabetes Metab. 2007;33 Suppl 1:S10-8.